Pembrolizumab: a beacon of hope for clear-cell renal-cell carcinoma patients post-nephrectomy

被引：0
|
作者：
Anand, Ayush [1 ,2 ]
Banda, Godfrey T. [12 ]
Satapathy, Prakasini [3 ,13 ]
Sharma, Rakesh Kumar [4 ,5 ]
Sharma, Divya [7 ]
Arora, Mithhil [8 ]
Khatib, Mahalaqua Nazli [9 ]
Gaidhane, Shilpa [10 ]
Zahiruddin, Quazi Syed [11 ]
Rustagi, Sarvesh [6 ]
机构：
[1] BP Koirala Inst Hlth Sci, Dharan, Nepal
[2] MediSurg Res, Darbhanga, India
[3] Saveetha Univ, Saveetha Med Coll & Hosp, Saveetha Inst Med & Tech Sci, Ctr Global Hlth Res, Chennai, India
[4] Graph Era, Dehra Dun, India
[5] Graph Era Hill Univ, Clement Town, India
[6] Uttaranchal Univ, Sch Appl & Life Sci, Dehra Dun, Uttarakhand, India
[7] Chitkara Univ, Ctr Res Impact & Outcome, Rajpura, Punjab, India
[8] Chitkara Univ, Chitkara Ctr Res & Dev, Baddi, Himachal Prades, India
[9] Global Consortium Publ Hlth & Res, Div Evidence Synth, Miami, FL USA
[10] Jawaharlal Nehru Med Coll, One Hlth Ctr COHERD, Belgaum, India
[11] Datta Meghe Inst Higher Educ, South Asia Infant Feeding Res Network SAIFRN, Global Consortium Publ Hlth & Res, Div Evidence Synth, Wardha, India
[12] Kamuzu Univ Hlth Sci, Blantyre 30184, Malawi
[13] Al Mustaqbal Univ, Med Labs Tech Dept, Hillah, Babil, Iraq
来源：
INTERNATIONAL JOURNAL OF SURGERY OPEN | 2024年 / 62卷 / 04期
关键词：
ADJUVANT PEMBROLIZUMAB;
D O I：
10.1097/IO9.0000000000000085
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
引用
收藏
页码：493 / 495
页数：3
相关论文
共 50 条
  • [21] Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
    Chatwal, Monica Sheila
    Chahoud, Jad
    Spiess, Philippe E.
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 314 - 326
  • [22] Change in renal function post-nephrectomy for renal cell carcinoma in patients with and without hypertension and/or diabetes
    John, J.
    Henry, M.
    Ringoir, A.
    Pinto, G.
    Kesner, K.
    Lazarus, J.
    Sinha, S.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2020, 58 (02) : 101 - 104
  • [23] Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States
    Lai, Yizhen
    Bensimon, Arielle G.
    Gao, Emily
    Bhattacharya, Rituparna
    Xu, Ruifeng
    Chevure, Jestinah
    Imai, Kentaro
    Haas, Naomi B.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : 612.e1 - 612.e11
  • [24] Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma?
    Gafanov, R. A.
    Dzidzaria, A. G.
    Kravtsov, I. B.
    Fastovets, S., V
    ONKOUROLOGIYA, 2020, 16 (03): : 29 - 37
  • [25] IMAGE-ANALYSIS OF PCNA EXPRESSION IN RENAL-CELL CARCINOMA, CLEAR-CELL TYPE ASSOCIATED WITH ACQUIRED CYSTIC-DISEASE (ACD) - COMPARISON TO CLASSIC RENAL-CELL CARCINOMA, CLEAR-CELL TYPE
    KHURANA, KK
    TRUONG, LD
    ROBINS, DB
    VERANI, RR
    LABORATORY INVESTIGATION, 1995, 72 (01) : A79 - A79
  • [26] Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice
    Thiery-Vuillemin, Antoine
    Cholley, Tiphaine
    Calcagno, Fabien
    Hugues, Marion
    Maurina, Tristan
    Limat, Samuel
    Thierry Nguyen Tan Hon
    Almotlak, Hamadi
    Mouillet, Guillaume
    Nerich, Virginie
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E297 - E305
  • [27] Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients
    Fernandes, Flavia Goncalves
    Silveira, Henrique Cesar Santejo
    Junior, Joao Neif Antonio
    da Silveira, Rosana Antunes
    Zucca, Luis Eduardo
    Carcano, Flavio Mavignier
    Sanches, Andre Octavio Nicolau
    Neder, Luciano
    Scapulatempo-Neto, Cristovam
    Serrano, Sergio Vicente
    Jonasch, Eric
    Reis, Rui Manuel
    Evangelista, Adriane Feijo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 14
  • [28] A four-gene signature predicts survival in clear-cell renal-cell carcinoma
    Dai, Jun
    Lu, Yuchao
    Wang, Jinyu
    Yang, Lili
    Han, Yingyan
    Wang, Ying
    Yan, Dan
    Ruan, Qiurong
    Wang, Shaogang
    ONCOTARGET, 2016, 7 (50) : 82712 - 82726
  • [29] Sorafenib improves progression-free survival in clear-cell renal-cell carcinoma
    不详
    FORMULARY, 2007, 42 (05) : 312 - 313
  • [30] Adjuvant Pembrolizumab in Renal-Cell Carcinoma
    Chakiryan, Nicholas H.
    Strother, Marshall C.
    Choueiri, Toni K.
    Powles, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 185 - 186
12345